NORTHWEST BIOTHERAPEUTICS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Northwest Biotherapeutics Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Northwest Biotherapeutics Inc Return On Equity for the quarter ending September 30, 2024 was 94.1 %, a 3.64% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Return On Equity for 2023 was 99 %, a 5.87% increase from 2022.
  • Northwest Biotherapeutics Inc annual Return On Equity for 2022 was 93.5 %.
  • Northwest Biotherapeutics Inc annual Return On Equity for 2021 was -63.5 %, a 121% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 99 +5.49 +5.87% Jan 1, 2023 Dec 31, 2023
2022 93.5 +157 Jan 1, 2022 Dec 31, 2022
2021 -63.5 -368 -121% Jan 1, 2021 Dec 31, 2021
2020 305 +266 +683% Jan 1, 2020 Dec 31, 2020
2019 39 -16 -29.2% Jan 1, 2019 Dec 31, 2019
2018 55 -106 -65.8% Jan 1, 2018 Dec 31, 2018
2017 161 -405 -71.6% Jan 1, 2017 Dec 31, 2017
2016 566 +346 +158% Jan 1, 2016 Dec 31, 2016
2015 220 -207 -48.5% Jan 1, 2015 Dec 31, 2015
2014 427 +135 +46.2% Jan 1, 2014 Dec 31, 2014
2013 292 +46.2 +18.8% Jan 1, 2013 Dec 31, 2013
2012 246 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.